Baseline serum uric acid level is associated with progression-free survival, disease control rate, and safety in postoperative patients with colorectal cancer treated by FOLFOX, FOLFIRI, or XELOX

Xi Zhang(Army Medical University), Xiaoshan Zhao(Zhujiang Hospital), Jing-ru Cheng(First Affiliated Hospital of Zhengzhou University), Yi-fen Wu(Dongguan People’s Hospital), Jing-xin Lin(TCM-Intigrated Cancer Center of Southern Medical University), Ruisi Zhou(Nanfang Hospital), Yanting You(Zhujiang Hospital), Xinghong Zhou(TCM-Intigrated Cancer Center of Southern Medical University), Qinghong Chen(TCM-Intigrated Cancer Center of Southern Medical University), Jia-man Lin(TCM-Intigrated Cancer Center of Southern Medical University), Siqi Wu(TCM-Intigrated Cancer Center of Southern Medical University), Jie Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanyan Liu(TCM-Intigrated Cancer Center of Southern Medical University), Yanchun Li(Medical University of South Carolina), Dongqing Wang(TCM-Intigrated Cancer Center of Southern Medical University), Xiaohu Chen(Nanjing University of Chinese Medicine), Ying Yang(Peking University), Qiang Zuo(Nanfang Hospital), Qiuxing He(TCM-Intigrated Cancer Center of Southern Medical University), Tianyu Zhong(Gannan Medical University)
Frontiers in Oncology
July 25, 2022
Cited by 4


Related Papers